Griffith & Werner’s Pfizer PFE Stock Holding History

Griffith & Werner’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.89M	Buy	161,427 +11,906	+8%	+$311K	1.82%	22
2026 Q1	$4.2M	Buy	149,521 +5,383	+4%	+$143K	2.08%	20
2025 Q4	$3.59M	Buy	144,138 +2,596	+2%	+$65.5K	1.83%	21
2025 Q3	$3.45M	Buy	+141,542	New	+$3.49M	1.79%	21
2025 Q1	$2.95M	Buy	116,596 +13,679	+13%	+$358K	1.84%	21
2024 Q4	$2.73M	Buy	+102,917	New	+$2.79M	1.8%	20

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Griffith & Werner's PFE Position: Q2 2026 in Review

Griffith & Werner increased its Pfizer (PFE) stake by 8% in Q2 2026, buying an estimated $311K and bringing the position to 161,427 shares worth $3.89M. The position accounts for 1.82% of the portfolio, ranked #22.

Griffith & Werner first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.2M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Griffith & Werner held 161,427 shares of Pfizer worth $3.89M as of Q2 2026.
Griffith & Werner bought 11,906 Pfizer shares in Q2 2026, an estimated $311K.
Pfizer made up 1.82% of Griffith & Werner's portfolio in Q2 2026, its #22 holding.
Griffith & Werner first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
Griffith & Werner's Pfizer position peaked at $4.2M in Q1 2026.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Griffith & Werner's 13F filing for Q2 2026, filed 30 Jul 2026.